The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Blog I

Executive Director of Drug Safety

May 25, 2015
Isis Pharmaceuticals retains TCG once again to help build their MD leadership in Drug Safety. For more information, contact Ken at 913.663.3100 or email him… Continue Reading →

Akcea Therapeutics Begins Search for Chief Medical Officer

May 18, 2015
Akcea Therapeutics has retained The Chase Group to secure a Chief Medical Officer to join the start-up organization. This person will be responsible for the… Continue Reading →

Entasis Therapeutics Retains The Chase Group for Chief Medical Officer Position

April 21, 2015
Entasis Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of medical affairs,… Continue Reading →

Esperion Therapeutics Partners with The Chase Group

February 18, 2015
Esperion Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of clinical research… Continue Reading →

Ipsen Neurology Franchise VP Secured

January 14, 2015 0 Comments
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired… Continue Reading →

The Chase Group Fills Key Leadership Role for Marinus Pharmaceuticals

January 12, 2015
The Chase Group is proud to announce the completion of a search for the Chief Medical Officer for Marinus Pharmaceuticals with the hiring of Albena… Continue Reading →

Acorda Therapeutics and The Chase Group Partner Once Again

January 12, 2015
Acorda Therapeutics has retained The Chase Group to secure a Medical Director of Clinical and Medical Affairs to join their rapidly expanding clinical development team…. Continue Reading →

RRD International Retains The Chase Group

January 12, 2015
RRD International has retained The Chase Group to secure a Chief Development Officer to direct and manage the day-to-day activities of all RRD International product… Continue Reading →

Ipsen VP Neurology Franchise Secured

January 12, 2015
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired… Continue Reading →

Ipsen Biosciences Retains The Chase Group for Neuroendocrine Position

October 23, 2014
Ipsen Biosciences has retained The Chase Group to secure a Director of Molecular and Cellular Endocrinology who will lead the company’s research programs to devise… Continue Reading →
© Copyright 1993-2021 The Chase Group; All Rights Reserved.